Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Tinea pedis

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    15 result(s) found for: Tinea pedis. Displaying page 1 of 1.
    EudraCT Number: 2008-002399-92 Sponsor Protocol Number: MP/clin/001-Ter Start Date*: 2008-10-08
    Sponsor Name:MedPharm Ltd.
    Full Title: A phase IIa randomised, observer-blind, comparative study of the efficacy, tolerability and consumer acceptability of topical MedSpray™ TP 1 % versus Lamisil® Once 1 % in the treatment of tinea pedis
    Medical condition: tinea pedis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10043873 Tinea pedis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-002851-40 Sponsor Protocol Number: CLOTAIS01/2019 Start Date*: 2020-08-27
    Sponsor Name:ANTIBIOTICE SA
    Full Title: A Randomized, Parallel Design, Multiple-Site Study to Evaluate the non-inferiority of generic Clotrimazole 10mg/g cream (Antibiotice SA) compared to Canesten® 10mg/g cream in Patients with Tinea Pedis
    Medical condition: Tinea Pedis
    Disease: Version SOC Term Classification Code Term Level
    21.1 10021881 - Infections and infestations 10043873 Tinea pedis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: RO (Trial now transitioned) HU (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-016626-14 Sponsor Protocol Number: H552000-0919 Start Date*: Information not available in EudraCT
    Sponsor Name:Almirall Hermal GmbH
    Full Title: A Phase IIa, two-center, randomized, double-blind study with parallel groups to evaluate the anti-mycotic and anti-inflammatory efficacy of topical combinational product LAS 41003 versus correspond...
    Medical condition: 120 male or female patients with symptomatic moderate to severe tinea pedis will be randomized
    Disease: Version SOC Term Classification Code Term Level
    12.0 10043873 Tinea pedis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-004695-49 Sponsor Protocol Number: 08-01 / Ter-C Start Date*: 2009-01-13
    Sponsor Name:Dermapharm AG
    Full Title: Doppelblinde, randomisierte klinische Studie zum Vergleich der Wirksamkeit und Verträglichkeit von Terbinafin Creme 1% vs. Lamisil® Creme vs. Grundlage bei Patienten mit Tinea pedis
    Medical condition: Tinea pedis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10043873 Tinea pedis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-005654-21 Sponsor Protocol Number: 13957 Start Date*: 2009-09-11
    Sponsor Name:Bayer Consumer Care AG
    Full Title: An investigator-blind, randomized, multicenter, 5-arm, placebo- and active controlled parallel group pilot trial to explore the efficacy and tolerability of topical bifonazole liquid spray in patie...
    Medical condition: Athlete’s foot, moderate severity.
    Disease: Version SOC Term Classification Code Term Level
    12.0 10003621 Athlete's foot LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-000775-15 Sponsor Protocol Number: TERBI 06/05 Start Date*: 2006-09-11
    Sponsor Name:PLIVA - ISTRAŽIVANJE I RAZVOJ d.o.o.
    Full Title: Double blind, comparative, randomized, placebo controlled, clinical study of therapeutic equivalence and tolerability of the topical preparation Terbinafine cream 1% (Pliva Croatia) with the medica...
    Medical condition: Uncomplicated Tinea pedis.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-007067-16 Sponsor Protocol Number: TERJ001 Start Date*: 2009-02-11
    Sponsor Name:JELFA SA
    Full Title: Randomised, double-blind, parallel-group, comparative study of two terbinafine products
    Medical condition: tinea pedis (interdigital, Athlet´s foot)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-002644-23 Sponsor Protocol Number: MB_PDT_1 Start Date*: 2020-07-23
    Sponsor Name:Dept. of Dermatology, Zealand University Hospital, Roskilde
    Full Title: Photodynamic therapy of antifungal resistant dermatophytes
    Medical condition: Competent patients over 18 years old with mycological verified antifungal resistant dermatophytosis
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10043870 Tinea infections HLT
    20.0 10021881 - Infections and infestations 10043868 Tinea cruris PT
    20.0 10021881 - Infections and infestations 10060889 Tinea infection PT
    21.1 10021881 - Infections and infestations 10043873 Tinea pedis PT
    20.0 10021881 - Infections and infestations 10049591 Tinea imbricata PT
    20.0 10021881 - Infections and infestations 10067197 Tinea manuum PT
    20.0 10021881 - Infections and infestations 10043872 Tinea NOS LLT
    20.1 10021881 - Infections and infestations 10043869 Tinea infection NOS LLT
    20.0 10021881 - Infections and infestations 10043867 Tinea corporis LLT
    20.0 10021881 - Infections and infestations 10043864 Tinea LLT
    20.0 10021881 - Infections and infestations 10053041 Tinea trichophytina cruris LLT
    20.0 10021881 - Infections and infestations 10073383 Tinea of hand LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-006513-33 Sponsor Protocol Number: KETFUN3001 Start Date*: 2007-05-23
    Sponsor Name:Janssen Pharmaceutica NV
    Full Title: A double-blind, randomized, parallel group comparison of Nizoral® cream (F012), ketoconazole 2% cream (F126) and placebo (F000) in the treatment of interdigital Tinea Pedis.
    Medical condition: For the treatment of tinea pedis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-001263-32 Sponsor Protocol Number: 241011BS Start Date*: 2006-07-21
    Sponsor Name:York Pharma GmbH
    Full Title: Phase III study to evaluate the anti-mycotic efficacy of a topical Abafungin formulation in patients with tinea pedis
    Medical condition: Patients with tinea pedis interdigitalis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) DE (Completed) IS (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-000940-10 Sponsor Protocol Number: RE&D VÚFB/8/2005/Tol-5 Start Date*: 2005-07-04
    Sponsor Name:RE&D VÚFB, s.r.o.
    Full Title: Evaluation of tolerance and efficacy of preparation TERBINAFIN HBF CREAM (Herbacos-Bofarma) and its comparison with preparation LAMISIL CREAM (Novartis) in patients with interdigital form of tinea ...
    Medical condition: tinea pedis var. interdigitale
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-002112-26 Sponsor Protocol Number: 139B7 Start Date*: 2007-05-21
    Sponsor Name:YORK Pharma GmbH
    Full Title: Open, single-arm phase-III study to investigate the percutaneous absorption of abafungin after topical dermal application of Abafungin cream 1.0 % (YORK Pharma GmbH) in 20 patients with tinea pedis...
    Medical condition: Tinea pedis interdigital
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-002842-20 Sponsor Protocol Number: 241012BS Start Date*: 2005-09-29
    Sponsor Name:York Pharma GmbH
    Full Title: Phase II dose ranging study to evaluate the anti-mycotic efficacy of topical Abafungin formulations in patients with tinea pedis.
    Medical condition: patients
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2016-001242-25 Sponsor Protocol Number: BBT120126032001 Start Date*: 2017-02-07
    Sponsor Name:Blueberry Therapeutics Ltd.
    Full Title: An Early Phase Development, Partly Blinded, Positive and Vehicle Controlled, Randomized, Non-inferiority Investigation of the Pharmacokinetics, Safety and Efficacy of BB2603 Cutaneous Hand-Pump Spr...
    Medical condition: Onychomycosis and associated Tinea Pedis
    Disease: Version SOC Term Classification Code Term Level
    21.1 10021881 - Infections and infestations 10043873 Tinea pedis PT
    20.0 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-001239-32 Sponsor Protocol Number: EBERTOIII/05ES01 Start Date*: 2005-09-02
    Sponsor Name:Laboratorios SALVAT, S.A.
    Full Title: Ensayo clínico multicéntrico, aleatorizado, paralelo, doble ciego, para evaluar la eficacia y seguridad de eberconazol solución 1% frente a placebo en el tratamiento de las dermatofitosis
    Medical condition: Dermatofitosis
    Disease: Version SOC Term Classification Code Term Level
    10012504
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 09 22:50:51 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA